No Data
No Data
Scinai Immunotherapeutics Files to Sell 3.02M ADS for Holders
Scinai Immunotherapeutics Secures $10 Million Equity Purchase Agreement
Scinai to Connect With Investors and Pharma Leaders at Upcoming Key US Conferences
Scinai Immunotherapeutics Share Are Trading Higher After the Company Announced Today the Establishment of a U.S.-based Subsidiary for Its Contract Development and Manufacturing Services.
Express News | Scinai Immunotherapeutics Share Are Trading Higher After the Company Announced Today the Establishment of a U.S.-based Subsidiary for Its Contract Development and Manufacturing Services
Scinai Immunotherapeutics Announces The Establishment Of A U.S.-Based Subsidiary For Its Contract Development And Manufacturing Services